Literature DB >> 1417175

Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices.

M J Orloff1, M S Orloff, M Rambotti, B Girard.   

Abstract

A prospective evaluation was conducted of 94 unselected patients ("all comers") with biopsy-proven Child's class C cirrhosis (93% alcoholic) and endoscopically proven acutely bleeding esophageal varices who underwent emergency portacaval shunt (EPCS) (85% side-to-side, 15% end-to-side) within 8 hours of initial contact (mean, 6.1 hours) during the past 12 years. Follow-up has been 100% and includes all patients for at least 1 year, and 61 patients (65%) for 5 to 12 years. Incidence of serious risk factors on initial contact was: ascites, 97%; jaundice, 86%; portal-systemic encephalopathy including past history, 71%; severe muscle wasting, 96%; alcohol ingestion within 7 days, 66%; delirium tremens, 16%; serum albumin, less than or equal to 2.5 g/dL 76%; indocyanine green dye retention greater than or equal to 50% in 45 minutes, 66%; serum glutamic-oxaloacetic transaminase greater than or equal to 100 units/L, 60%; hyperdynamic cardiac output greater than or equal to 6 L/minute, 98%. Mean Child's point score was 13.7 out of a maximum of 15. EPCS reduced mean corrected free portal pressure from 286 to 23 mm saline, and permanently controlled variceal bleeding in every patient. Of the 94 patients, 74 (80%) left the hospital alive and 68 (72%) survived 1 year. Five-year actuarial survival rate is 64%. Hepatic failure was the main cause of death during initial hospitalization as well as during follow-up, when it was related to continued alcoholism. Portal-systemic encephalopathy, which was present on initial contact in 55% of patients, occurred at some time during follow-up in 18.7%, but was recurrent and required dietary protein restriction in only 9%, all of whom had resumed alcoholism. The low incidence of portal-systemic encephalopathy was attributable to the lifelong program of follow-up with regular dietary counseling and continued emphasis on both protein restriction to 60 g/day and abstinence from alcohol. Abstinence was sustained in 69%, liver function improved in 82%, general health was judged excellent or good in 73%, and Child's risk class converted to class B in 73% and class A in 21%. Excluding retirees because of age, 42% were gainfully employed or engaged in full-time housekeeping. Long-term shunt patency was documented in 100% of survivors by yearly angiography or Doppler ultrasonography. It is concluded that EPCS within 8 hours of initial contact permanently controls variceal hemorrhage and results in prolonged survival and a life of acceptable quality in many alcoholic cirrhotic patients in Child's class C.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1417175      PMCID: PMC1242604          DOI: 10.1097/00000658-199209000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  59 in total

1.  Survival prediction in portacaval shunts: a computerized statistical analysis.

Authors:  D P Campbell; D E Parker; C E Anagnostopoulos
Journal:  Am J Surg       Date:  1973-12       Impact factor: 2.565

2.  The natural history of esophageal varices. A retrospective study of 224 cases with liver cirrhosis.

Authors:  R Olsson
Journal:  Digestion       Date:  1972       Impact factor: 3.216

3.  Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse.

Authors:  G L Bird; J G O'Grady; F A Harvey; R Y Calne; R Williams
Journal:  BMJ       Date:  1990-07-07

4.  Liver transplantation in patients with previous portasystemic shunt.

Authors:  V Mazzaferro; S Todo; A G Tzakis; A C Stieber; L Makowka; T E Starzl
Journal:  Am J Surg       Date:  1990-07       Impact factor: 2.565

5.  Acute esophageal variceal sclerotherapy. Results of a prospective randomized controlled trial.

Authors:  A W Larson; H Cohen; B Zweiban; D Chapman; M Gourdji; J Korula; J Weiner
Journal:  JAMA       Date:  1986 Jan 24-31       Impact factor: 56.272

6.  Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk.

Authors:  W K Huizinga; I B Angorn; L W Baker
Journal:  Surg Gynecol Obstet       Date:  1985-06

7.  Course and complications of endoscopic variceal sclerotherapy: a prospective study of 50 patients.

Authors:  H E Sarles; R A Sanowski; G Talbert
Journal:  Am J Gastroenterol       Date:  1985-08       Impact factor: 10.864

8.  Portasystemic shunting remains the procedure of choice for control of variceal hemorrhage.

Authors:  B A Levine; H V Gaskill; K R Sirinek
Journal:  Arch Surg       Date:  1985-03

9.  Long-term sclerotherapy of bleeding esophageal varices in patients with liver cirrhosis. An evaluation of mortality and rebleeding risk factors.

Authors:  T Sauerbruch; M Weinzierl; W Köpcke; G Paumgartner
Journal:  Scand J Gastroenterol       Date:  1985-01       Impact factor: 2.423

10.  Results in 100 consecutive patients with stapled esophageal transection for varices.

Authors:  R A Spence; G W Johnston
Journal:  Surg Gynecol Obstet       Date:  1985-04
View more
  10 in total

1.  Transjugular intrahepatic portosystemic shunt (TIPS) for variceal bleeding in portal hypertension: comparison of emergency and elective interventions.

Authors:  A L Gerbes; V Gülberg; T Waggershauser; J Holl; M Reiser
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 2.  Hepatic disorders. Features and appropriate management.

Authors:  M A Aldersley; J G O'Grady
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

Review 3.  Portal hypertension management.

Authors:  J Terblanche
Journal:  Surg Endosc       Date:  1993 Nov-Dec       Impact factor: 4.584

4.  Portal vein thrombosis in cirrhosis with variceal hemorrhage.

Authors:  M J Orloff; M S Orloff; S L Orloff; B Girard
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

5.  Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis.

Authors:  Marshall J Orloff; Florin Vaida; Kevin S Haynes; Robert J Hye; Jon I Isenberg; Horacio Jinich-Brook
Journal:  J Gastrointest Surg       Date:  2012-09-25       Impact factor: 3.452

Review 6.  Current state of portosystemic shunt surgery.

Authors:  Martin Wolff; Andreas Hirner
Journal:  Langenbecks Arch Surg       Date:  2003-03-29       Impact factor: 3.445

7.  Role of liver transplantation in management of esophageal variceal hemorrhage.

Authors:  B Ringe; H Lang; G Tusch; R Pichlmayr
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

Review 8.  Surgical management of acute variceal hemorrhage.

Authors:  L F Rikkers; G Jin
Journal:  World J Surg       Date:  1994 Mar-Apr       Impact factor: 3.352

9.  Fifty years of surgery for portal hypertension at the Cleveland Clinic Foundation. Lessons and prospects.

Authors:  R E Hermann; J M Henderson; D P Vogt; J T Mayes; M A Geisinger; C Agnor
Journal:  Ann Surg       Date:  1995-05       Impact factor: 12.969

10.  Beneficial effect of partial portal decompression using the inferior mesenteric vein for intractable gastroesophageal variceal bleeding in patients with liver cirrhosis.

Authors:  Satoshi Yamamoto; Yoshinobu Sato; Hideki Nakatsuka; Hiroshi Oya; Takashi Kobayashi; Katsuyoshi Hatakeyama
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.